abstract |
The invention relates to the use of fumaric acid and the derivatives, either individually or in mixtures, in the production of a medicament for prophylactic use or treatment of AGE induced genome damage. The invention more particularly relates to the use of fumaric acid derivatives in patients suffering from kidney insufficiency or diabetes mellitus. |